Sunday, March 29, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Commodities

Silver Finds Support in Physical Supply Squeeze

SiterGedge by SiterGedge
March 29, 2026
in Commodities, Gold & Precious Metals, Market Commentary
0
Silber Preis Stock
0
SHARES
5
VIEWS
Share on FacebookShare on Twitter

A fundamental supply issue is now taking center stage in the silver market, cutting through weeks of price volatility. Critical physical inventories are being drawn down at a rapid pace, creating a supportive backdrop for the industrial metal. This dynamic is being driven by a confluence of factors: stringent export controls from a major producer and alarmingly depleted stockpiles in key trading hubs.

Geopolitical Tensions Amplify Demand

Beyond the tangible supply crunch, geopolitical developments are fueling demand. Recent reports of potential disruptions to shipping through the Strait of Hormuz have put commodity markets on high alert. In such an environment, silver’s dual role as an essential industrial input and a perceived safe-haven asset comes to the fore. This was reflected in recent trading, with the metal closing the Friday session at $69.76, a gain of 1.11 percent. This move helps to stabilize prices after a challenging 30-day period that saw silver decline by more than 22 percent.

Should investors sell immediately? Or is it worth buying Silber Preis?

Warehouse Inventories Evaporate

Data from COMEX warehouses reveals the extent of the supply pressure. By the end of February, registered silver stocks had fallen to approximately 86.1 million ounces. This represents a dramatic drop of over 30 percent in just a few months. The global supply deficit is being structurally exacerbated by policy moves. Since the start of the year, China, a crucial exporter, has been restricting shipments of refined silver. For the global semiconductor industry, this translates into a tangible shortage of a vital raw material.

Strong Fundamentals Amid Price Correction

While the current price near $70 marks a significant pullback from the 52-week high of $116.89 reached in late January, underlying fundamentals appear robust. Although silver continues to trade about 16 percent below its 50-day moving average, a key metric suggests relative strength. The gold-to-silver ratio has declined to a range between 55 and 62, indicating silver is gaining ground against its more expensive peer. As long as Chinese export restrictions remain in place and geopolitical risks stay elevated, these core factors are likely to provide a floor, insulating the silver price from steeper declines.

Ad

Silber Preis Stock: Buy or Sell?! New Silber Preis Analysis from March 29 delivers the answer:

The latest Silber Preis figures speak for themselves: Urgent action needed for Silber Preis investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 29.

Silber Preis: Buy or sell? Read more here...

Tags: Silber Preis
SiterGedge

SiterGedge

Related Posts

Avantis® Emerging Markets Equity ETF Stock
Analysis

Technical Breakdown Threatens Avantis Emerging Markets ETF

March 29, 2026
iShares MSCI Global Metals & Mining Producers ETF Stock
Asian Markets

Metals and Mining ETF Navigates Crosscurrents of Geopolitics and Demand

March 29, 2026
Almonty Stock
Analysis

Almonty Industries: Analyst Forecasts Surge Amidst Valuation Debate

March 29, 2026
Next Post
Valero Energy Stock

Structural Tailwinds Propel Valero Energy Shares to New Heights

Occidental Petroleum Stock

A New Chapter Begins: Leadership Transition at Occidental Petroleum

Kohl's Stock

Kohl's Strategic Pivot: Private Brands Take Center Stage

Recommended

Arvinas Stock

Arvinas Shares a Key Development in Parkinson’s Disease Treatment

1 week ago
Textron Stock

Textron Stock Approaches Annual Peak Amid Strategic Wins

3 months ago

Groundbreaking Phase 1b2 Clinical Trial Explores the Potential of LB100 and Dostarlimabgxly for Ovarian Clear Cell Carcinoma

2 years ago
NextDecade Stock

NextDecade Shares Face Pressure Despite Major Backing and Leadership Transition

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Pfizer Shares Buoyed by Dual Clinical Trial Victories and Strategic Momentum

Mirum Pharmaceuticals: A Pivotal Year of Clinical Catalysts and Financial Milestones

Procter & Gamble Shares: A Clash of Institutional and Insider Sentiment

MPLX Charts a Course for Growth Through Natural Gas Infrastructure

Kohl’s Strategic Pivot: Private Brands Take Center Stage

A New Chapter Begins: Leadership Transition at Occidental Petroleum

Trending

Avantis® Emerging Markets Equity ETF Stock
Analysis

Technical Breakdown Threatens Avantis Emerging Markets ETF

by Kennethcix
March 29, 2026
0

The Avantis® Emerging Markets Equity ETF (AVEM) is approaching a pivotal juncture, with technical indicators flashing warning...

iShares MSCI Global Metals & Mining Producers ETF Stock

Metals and Mining ETF Navigates Crosscurrents of Geopolitics and Demand

March 29, 2026
Porsche Holding Stock

Porsche SE Cuts Shareholder Payout Amid Sector Headwinds

March 29, 2026
Pfizer Stock

Pfizer Shares Buoyed by Dual Clinical Trial Victories and Strategic Momentum

March 29, 2026
Mirum Pharmaceuticals Stock

Mirum Pharmaceuticals: A Pivotal Year of Clinical Catalysts and Financial Milestones

March 29, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Technical Breakdown Threatens Avantis Emerging Markets ETF
  • Metals and Mining ETF Navigates Crosscurrents of Geopolitics and Demand
  • Porsche SE Cuts Shareholder Payout Amid Sector Headwinds

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com